Best of the Week
Most Popular
1. Climate Change Mass Extinction - Birds, Bees and Bugs: Going Going Gone - Richard_Mills
2.A Purrrfect Gold Price Setup! - Peter_Degraaf
3.Who Finances America's Borrowing? Recession Indicator for Independent Thinkers Part 2 - F_F_Wiley
4.America’s One-sided Domestic Financial War - Raymond_Matison
5.Gold Price Summer Doldrums - Zeal_LLC
6.Two Key Events Will Unleash Gold - Jim_Willie_CB
7.Billionaire Schools Teacher in NAFTA Trade Talks - Richard_Mills
8.Get Out Of Crypto Cannabis Bubble Before It Pops and Move Into Bargain Basement Miners - Jeb_Handwerger
9.Stock Market Could Pullback for 1-2 weeks, But Medium Term Bullish - Troy_Bombardia
10.G7 Chaos, Central Banks and US Fed Will Drive Stock Prices This Week - Chris_Vermeulen
Last 7 days
Gold GLD ETF Update… Breakdown ? - 20th Jun 18
Short-term Turnaround in Bitcoin Might Not Be What You Think - 19th Jun 18
Stock Market’s Short Term Downside Will be Limited - 19th Jun 18
Natural Gas Setup for 32% Move in UGAZ Fund - 19th Jun 18
Magnus Collective To Empower Automation And Artificial Intelligence - 19th Jun 18
Trump A Bull in a China Shop - 19th Jun 18
Minor Car Accident! What Happens After You Report Your Accident to Your Insurer - 19th Jun 18
US Majors Flush Out A Major Pivot Low and What’s Next - 18th Jun 18
Cocoa Commodities Trading Analysis - 18th Jun 18
Stock Market Consolidating in an Uptrend - 18th Jun 18
Russell Has Gone Up 7 Weeks in a Row. EXTREMELY Bullish for Stocks - 18th Jun 18
What Happens Next to Stocks when Tech Massively Outperforms Utilities and Consumer Staples - 18th Jun 18
The Trillion Dollar Market You’ve Never Heard Of - 18th Jun 18
The Corruption of Capitalism - 17th Jun 18
North Korea, Trade Wars, Precious Metals and Bitcoin - 17th Jun 18
Climate Change and Fish Stocks – Burning Oxygen! - 17th Jun 18
A $1,180 Ticket to NEW Trading Opportunities, FREE! - 16th Jun 18
Gold Bullish on Fed Interest Rate Hike - 16th Jun 18
Respite for Bitcoin Traders Might Be Deceptive - 16th Jun 18
The Euro Crashed Yesterday. Bearish for Euro and Bullish for USD - 15th Jun 18
Inflation Trade, in Progress Since Gold Kicked it Off - 15th Jun 18
Can Saudi Arabia Prevent The Next Oil Shock? - 15th Jun 18
The Biggest Online Gambling Companies - 15th Jun 18
Powell's Excess Reserve Change and Gold - 15th Jun 18
Is This a Big Sign of a Big Stock Market Turn? - 15th Jun 18
Will Italy Sink the EU and Boost Gold? - 15th Jun 18
Bumper Crash! Land Rover Discovery Sport vs Audi - 15th Jun 18
Stock Market Topping Pattern or Just Pause Before Going Higher? - 14th Jun 18
Is the ECB Ending QE a Good Thing? Markets Think So - 14th Jun 18
Yield Curve Continues to Flatten. A Bullish Sign for the Stock Market - 14th Jun 18
How Online Gambling has Impacted the Economy - 14th Jun 18
Crude Oil Price Targeting $58 ppb Before Finding Support - 14th Jun 18
Stock Market Near Another Top? - 14th Jun 18
Thorpe Park REAL Walking Dead Living Nightmare Zombie Car Park Ride Experience! - 14th Jun 18

Market Oracle FREE Newsletter

5 "Tells" that the Stock Markets Are About to Reverse

How to Ride the Biotech Boom

Companies / BioTech Jul 10, 2013 - 04:24 PM GMT

By: Investment_U

Companies

Marc Lichtenfeld writes: hope you had a great Fourth of July. I had a blast hanging out with family and friends. However, we had a long drive home so we missed the fireworks.

That’s OK, though. I’ve seen plenty of fireworks in the past two weeks in the biotech sector.

Since June 24, the Amex Biotech Index (NYSE: BTK) is up over 11%. That’s a solid year for most indexes. Year to date, the group is up over 34%.


Typically, biotech stocks, particularly those that deal with cancer, run up in the spring, ahead of the annual meeting of the American Society of Clinical Oncology (ASCO). At this meeting, nearly every major (and minor) player in the fight against cancer presents data from various clinical and preclinical trials.

After the ASCO meeting, which takes place the first week of June, biotech stocks usually take a breather, sometimes for the rest of the year until they start moving in anticipation of the J.P. Morgan Healthcare Conference – the first big one of the year – in early January.

Acquisition Fever Fuels Run-up
This year, biotech hit a high in mid-May and then backed off. But in late June the sector ignited. Fueling the fire was the proposed acquisition of Onyx Pharmaceuticals (Nasdaq: ONXX) by Amgen (Nasdaq: AMGN) for a 38% premium.

Onyx’s management rejected the proposal and put itself up for sale. The stock opened 53% higher and has climbed a few points since.

Other cancer stocks have also soared. ImmunoGen (Nasdaq: IMGN) is up 20% in the past few weeks. And Celldex Therapeutics (Nasdaq: CLDX), which has drugs in development for brain cancer and breast cancer, has spiked 63% in just two weeks.

Fortunately, these stocks are in my Healthcare Profits Alert service, so my subscribers have been enjoying the ride higher. But there have been plenty of other biotech stocks that are not in the portfolio that have been moving up as well: Alnylam (Nasdaq: ALNY), and Immunomedics (Nasdaq: IMMU) to name just a few.

Can the run-up continue? I believe it can.

Right now there is a lot of excitement over a possible acquisition of Onyx. If the company does in fact get bought at a decent premium, that’s going to make takeover speculation go into overdrive.

Plus, big pharmaceutical companies desperately need new drugs. And biotech can provide them. Smaller companies like Celldex Therapeutics can be bought at a much lower price than a larger company like Onyx. There are many small-cap biotechs with promising drugs that would not be an expensive purchase for a large pharma company like Merck (NYSE: MRK) or Bristol-Myers Squibb (NYSE: BMY).

Additionally, the technicals look strong:

The index recently broke out of a flag pattern. A flag is a short-term move that goes against the prevailing trend. You can see that the biotech index has been moving up since November, but in May and June the index took a break from its ascent. Now it has broken out above that flag pattern.

Flags are fairly reliable technical patterns. This one suggests that the index can still go meaningfully higher. I wouldn’t be surprised to see it hit 2,300 before the move is over.

How to Play It
If you agree, there are several ways to play this move. You can buy a biotech ETF like iShares Nasdaq Biotechnology (Nasdaq: IBB); you can find some biotech stocks with promising drugs that have shown efficacy and (very important) a strong safety profile in clinical trials; or you can rely on someone to help guide you, like the readers of my Healthcare Profits Alert do.

Whichever way you go, consider putting some of your speculative money to work in this sector, as there should be more spectacular gains on the way.

Editor’s Note: We need to tip our collective hats to Marc. As he mentions above, he is treating his followers to phenomenal profits. A perfect example comes from an alert he mailed his Healthcare Profits Alert subscribers yesterday. In it, Marc details the action to take on four profitable positions. One has tripled in price. Another is up by 229%. The third play is up 67%. And the fourth is up by 7%… in less than a month. Clearly, market volatility won’t shake Marc’s winning system. And that deserves a tip of our hat. To be one of the first to hear about his next winning recommendation, follow this link.

Source: http://www.investmentu.com/2013/July/ride-the-biotech-boom.html

http://www.investmentu.com

Copyright © 1999 - 2013 by The Oxford Club, L.L.C All Rights Reserved. Protected by copyright laws of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), of content from this website, in whole or in part, is strictly prohibited without the express written permission of Investment U, Attn: Member Services , 105 West Monument Street, Baltimore, MD 21201 Email: CustomerService@InvestmentU.com

Disclaimer: Investment U Disclaimer: Nothing published by Investment U should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized investment advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended by Investment U should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.

Investment U Archive

© 2005-2018 http://www.MarketOracle.co.uk - The Market Oracle is a FREE Daily Financial Markets Analysis & Forecasting online publication.


Post Comment

Only logged in users are allowed to post comments. Register/ Log in

6 Critical Money Making Rules